Department of Orthopedic Surgery, Rambam Health Care Campus, Haifa, Israel.
Int Orthop. 2010 Jun;34(5):621-30. doi: 10.1007/s00264-010-0959-y. Epub 2010 Feb 18.
Treatment of articular cartilage lesions in the knee remains a challenge for the practising orthopaedic surgeon. A wide range of options are currently practised, ranging from conservative measures through various types of operations and, recently, use of growth factors and emerging gene therapy techniques. The end result of these methods is usually a fibrous repair tissue (fibrocartilage), which lacks the biomechanical characteristics of hyaline cartilage that are necessary to withstand the compressive forces distributed across the knee. The fibrocartilage generally deteriorates over time, resulting in a return of the original symptoms and occasionally reported progression to osteoarthritis. Our purpose in this study was to review the aetiology, pathogenesis and treatment options for articular cartilage lesions of the knee. At present, autologous cell therapies, growth factor techniques and biomaterials offer more promising avenues of research to find clinical answers.
膝关节软骨损伤的治疗仍然是临床骨科医生面临的挑战。目前,有多种治疗方法,从保守治疗到各种手术,最近还包括生长因子和新兴的基因治疗技术。这些方法的最终结果通常是纤维修复组织(纤维软骨),它缺乏透明软骨的生物力学特性,无法承受分布在膝关节上的压缩力。纤维软骨通常会随着时间的推移而退化,导致原始症状再次出现,并且有时还会出现进展为骨关节炎的报道。我们在这项研究中旨在回顾膝关节软骨损伤的病因、发病机制和治疗选择。目前,自体细胞治疗、生长因子技术和生物材料为寻找临床答案提供了更有前途的研究途径。